Reset
Showing 20 of 144 academic articles

Peculiarities of personalized selection of antipsychotic drugs for schizophrenia treatment

O.O. Khaustova, A.E. Asanova, N.O. Dzeruzhynska, M.M. Matiash • Medičnì Perspektivi (2024)

Determining the optimal antipsychotic drugs, its effective dose, duration of therapy, form, and route of administration play a key role in the treatment of schizophrenia. In addition, special attention should be paid to the effectiveness of...

DOAJ Open Access (DOAJ) DOI: 10.26641/2307-0404.2024.1.300499

Sedative-hypnotic drug use and risk of falls and fractures in elderly patients: a cross-sectional study

Mohammad Hossein Imani, Amir Hossein Imani, Amirhossein Saem, Maryam Niksolat • BMC Geriatrics (2025)

Abstract Background Falls are a leading cause of injury, hospitalization, and mortality among older adults. Sedative-hypnotic medications, especially benzodiazepines and Z-drugs, have been implicated as potential contributors to fall risk a...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12877-025-06624-y

UPLC-MS/MS Metabolomics Reveals Babao Dan’s Mechanisms in MASH Treatment with Integrating Network Pharmacology and Molecular Docking

Shijiao Zhang, Yanding Su, Ao Han, He Qi et al. • Pharmaceuticals (2025)

Background: Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive disease that easily develops into cirrhosis and hepatocellular carcinoma, but its pathogenesis is not clear, and most therapeutic drugs have obvious limita...

DOAJ Open Access (DOAJ) DOI: 10.3390/ph18081111

Detection Techniques for Synthetic Cannabinoids in Body Fluids and Tissues: A Systematic Review

Sachil Kumar, Tulsidas R. Baggi • Journal of Forensic Science and Medicine (2026)

Synthetic cannabinoids (SCs), originally developed for research purposes in the 1960s, have emerged as a significant concern in clinical and forensic toxicology due to their widespread abuse and unpredictable toxicological effects. These co...

DOAJ Open Access (DOAJ) DOI: 10.4103/jfsm.jfsm_128_25

What motivates SARS-CoV-2 vaccine trial participants? A pre- and post-participation survey study

Olivia A. C. Lamers, Meta Roestenberg, Martine C. de Vries, Marie-Astrid Hoogerwerf • Trials (2024)

Abstract Background Scientific advancement, including the testing and licensing of new drugs, relies heavily on clinical trials with healthy individuals. The motivations of clinical trial participants have been discussed intensively, as som...

DOAJ Open Access (DOAJ) DOI: 10.1186/s13063-024-08582-z

VirtualToxLab™ - In silico prediction of the toxic (endocrine-disrupting) potential of drugs, chemicals and natural products. Two years and 2,000 compounds of experience: a progress report

Angelo Vedani, Martin Smiesko, Morena Spreafico, Ourania Peristera et al. • ALTEX: Alternatives to Animal Experimentation (2009)

The VirtualToxLab™ is an in silico tool for predicting the toxic (endocrine-disrupting) potential of drugs, chemicals and natural products. It is based on a fully automated protocol and calculates the binding affinity of any molecule of int...

DOAJ Open Access (DOAJ) DOI: 10.14573/altex.2009.3.167

Identification of Eusynstyelamide B as a Potent Cell Cycle Inhibitor Following the Generation and Screening of an Ascidian-Derived Extract Library Using a Real Time Cell Analyzer

Michelle S. Liberio, Martin C. Sadowski, Colleen C. Nelson, Rohan A. Davis • Marine Drugs (2014)

Ascidians are marine invertebrates that have been a source of numerous cytotoxic compounds. Of the first six marine-derived drugs that made anticancer clinical trials, three originated from ascidian specimens. In order to identify new anti-...

DOAJ Open Access (DOAJ) DOI: 10.3390/md12105222

Dietary Supplementation with the Red Seaweed <i>Porphyra umbilicalis</i> Protects against DNA Damage and Pre-Malignant Dysplastic Skin Lesions in HPV-Transgenic Mice

Susana Santos, Tiago Ferreira, José Almeida, Maria J. Pires et al. • Marine Drugs (2019)

Some diet profiles are associated with the risk of developing cancer; however, some nutrients show protective effects. Porphyra umbilicalis is widely consumed, having a balanced nutritional profile; however, its potential for cancer chemopr...

DOAJ Open Access (DOAJ) DOI: 10.3390/md17110615

Health Technology Assessment

Lise Lund Håheim, Berit Mørland • IGI Global eBooks (2011)

Scientific publications in medical fields are rapidly increasing and are overwhelming in numbers. This poses a challenge to health authorities, and health professionals who need knowledge to make informed decisions in finding the best evide...

OPENALEX DOI: https://doi.org/10.4018/978-1-60566-988-5.ch003

Health Technologies as a Cost-Driver in Canada

Paul V. Grootendorst, Hai Thanh Nguyen, Alexandra Constant, Minsup Shim • TSpace (University of Toronto) (2011)

This report describes our estimation of the effects of technological change (TC) on health care (HC) expenditures in Canada during the period 1996-2008. We focus on the effect of TC on overall nominal expenditures, as well as the effects of...

OPENALEX Open Access

Health Technology Assessment

Lise Lund Håheim, Berit Mørland • IGI Global eBooks (2009)

Scientific publications in medical fields are rapidly increasing and are overwhelming in numbers. This poses a challenge to health authorities, and health professionals who need knowledge to make informed decisions in finding the best evide...

OPENALEX DOI: https://doi.org/10.4018/978-1-60566-356-2.ch046

A Benzimidazole-Based N-Heterocyclic Carbene Derivative Exhibits Potent Antiproliferative and Apoptotic Effects against Colorectal Cancer

Sarah Al-Nasser, Maha Hamadien Abdulla, Noura Alhassan, Mansoor-Ali Vaali-Mohammed et al. • Medicina (2024)

Background and Objectives: Colorectal cancer (CRC) remains a major global health issue. Although chemotherapy is the first-line treatment, its effectiveness is limited due to drug resistance developed in CRC. To overcome resistance and impr...

DOAJ Open Access (DOAJ) DOI: 10.3390/medicina60091379

Health technology assessment in Switzerland

Pedro Koch, Julian Schilling, Marlène Laeubli Loud, Florian Mitscherlich et al. • International Journal of Technology Assessment in Health Care (2009)

OBJECTIVES AND METHODS: To review Switzerland's mixed public and private healthcare system with regard to health technology assessment (HTA). RESULTS: In the past, remarkable work in HTA was done. Accomplishments include the following: (i) ...

OPENALEX Open Access DOI: https://doi.org/10.1017/s0266462309090606

Analysing criteria for price and reimbursement of orphan drugs in Spain

Xavier Badia, Alicia Gil, José Luis Poveda-Andrés, John Shepherd et al. • Farmacia Hospitalaria (2019)

Objective: There are differences between countries regarding data requirements for orphan drug evaluation and it is also unknown which criteria might determine the price and reimbursement decision. This study aimed to identify the key c...

DOAJ Open Access (DOAJ) DOI: 10.7399/fh.11147

HEALTH TECHNOLOGY ASSESSMENT IN CANADA

Devidas Menon, Leigh-Ann Topfer • International Journal of Technology Assessment in Health Care (2000)

OBJECTIVES: Since 1988, four government-funded health technology assessment (HTA) agencies have been established in Canada. This paper is a descriptive review of reports issued by these organizations during the period from 1988 to 1998. MET...

OPENALEX DOI: https://doi.org/10.1017/s0266462300102168

Compounds of Marine Origin with Possible Applications as Healing Agents

Nektaria-Ioanna Karma, Fotini Mellou, Panagoula Pavlou, Angeliki Siamidi et al. • Marine Drugs (2024)

It is well established that marine organisms consist of a great variety of active compounds that appear exclusively in the marine environment while having the ability to be vastly reproduced, irrespective of the existing conditions. As a re...

DOAJ Open Access (DOAJ) DOI: 10.3390/md23010005

HEALTH TECHNOLOGY REASSESSMENT: THE ART OF THE POSSIBLE

Gail MacKean, Tom Noseworthy, Adam G. Elshaug, Laura E. Leggett et al. • International Journal of Technology Assessment in Health Care (2013)

BACKGROUND: Health technology reassessment (HTR) is "a structured, evidence-based assessment of the clinical, social, ethical, and economic effects of a technology currently used in the healthcare system, to inform optimal use of that techn...

OPENALEX cc-by-nc-sa DOI: https://doi.org/10.1017/s0266462313000494 PMC: 3846380